Sapanisertib, Carboplatin, and Paclitaxel in Treating Patients With Recurrent or Refractory Malignant Solid Tumors

Clinical trial NCT03430882 · COMPLETED

Trial details

NCT number: NCT03430882
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent Malignant Solid Neoplasm Refractory Malignant Solid Neoplasm

Start date: 2018-03-12
Primary completion: 2022-06-08
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.